August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Rob Michael Announces FDA Approval of AbbVie’s New NSCLC Therapy
May 16, 2025, 02:14

Rob Michael Announces FDA Approval of AbbVie’s New NSCLC Therapy

Rob Michael, Chief Executive Officer of AbbVie, posted on LinkedIn:

“Today, the U.S. FDA announced accelerated approval for AbbVie’s new medicine to treat certain types of advanced non-squamous non-small cell lung cancer (NSCLC). There is a need for new therapies for patients with difficult to treat tumors like NSCLC given the limited treatment options.
I am proud of our employees’ strong commitment to patients and their extensive efforts to make this approval possible.
Learn more here.”

More posts featuring FDA.